If the idea of using magnets to treat depression sounds too simple—or too experimental—you’re not alone. Transcranial magnetic stimulation (TMS) therapy may seem unconventional, but it’s an FDA-approved, non-invasive treatment that uses magnetic pulses to stimulate specific brain regions involved in mood regulation. Unlike antidepressants that circulate systemically throughout your bloodstream, TMS targets underactive neural pathways—making it a localized, hardware-based approach for people living with treatment-resistant depression.
For many adults exploring non-medication depression treatment options beyond traditional medication, TMS represents a shift in how we think about treating mental health conditions. Rather than relying on chemical adjustments that take weeks to build up in your system, this approach uses precise magnetic fields to reactivate areas that have become less responsive.
Nushama specializes in evidence-based approaches to treatment-resistant conditions, and while we focus primarily on ketamine-assisted therapy, we recognize the importance of understanding all advanced treatment options. This comprehensive guide to alternative depression treatments will walk you through what TMS actually does to your brain, what a typical session feels like at a Manhattan clinic, and how to think about TMS alongside other emerging therapies.
How does TMS work? Understanding the magnetic pulses
Transcranial magnetic stimulation (TMS) explained: TMS works by delivering magnetic fields through a coil placed against the scalp, stimulating nerve cells in the brain region that regulates mood —specifically the dorsolateral prefrontal cortex. This non-invasive procedure modulates neurotransmitter balance across multiple neural circuits, creating changes in brain activity without the systemic side effects of medication.
When the magnetic coil generates a pulse, it creates an electrical current in the targeted brain tissue. This current activates neurons that have become less responsive due to depression, essentially “waking up” areas of the brain that help regulate your emotional state. The treatment focuses on the dorsolateral prefrontal cortex because brain imaging studies consistently show reduced activity in this region among people living with depression.
By repeatedly stimulating this area, TMS encourages neuroplasticity—your brain’s natural ability to reorganize and form new connections. Over multiple sessions, these changes can become self-sustaining, potentially leading to lasting improvements in mood and emotional regulation.
Key features of TMS include:
- Magnetic pulses activate underactive regions involved in mood control
- Uses localized stimulation rather than systemic chemicals
- FDA-approved for treatment-resistant depression in adults and adolescents (age 15+)
- Also approved for obsessive-compulsive disorder (OCD), migraines, and smoking cessation
- Medical screening ensures safety and identifies contraindications like metal implants or seizure history
TMS protocols explained: standard 6-week vs. accelerated SAINT
While standard repetitive transcranial magnetic stimulation (rTMS) involves daily sessions over 4–6 weeks , accelerated protocols like SAINT condense treatment into high-intensity sessions for faster relief. For those who cannot commit to weeks of daily appointments—perhaps due to work schedules, caregiving responsibilities, or the urgency of their symptoms—these compressed alternatives offer hope.
The standard protocol involves coming to the clinic five days per week for several weeks, with each session lasting about half an hour. This schedule allows your brain time to adapt gradually to the stimulation, building cumulative benefit over time.
Accelerated SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) condenses the entire treatment timeline into just five days, with 10 sessions per day delivered in hourly intervals. For those requiring the most rapid intervention, ultra-accelerated one-day protocols deliver all sessions in a single 8-10 hour block—typically reserved for members in acute crisis.
Key differences between protocols:
- Standard rTMS: Daily 20–40 minute sessions over 4–6 weeks; widely covered by insurance
- SAINT: 10 sessions daily for 5 days; the initial 29-person trial showed 79% remission , with larger replication studies confirming 50% remission at one month—still more than double the sham treatment rate
- One-day protocol: All sessions in 8-10 hours; requires close medical monitoring
- Cost: Standard rTMS is usually covered by insurance; the full SAINT protocol at academic centers costs $30,000-$36,000, while the ONE-D single-day protocol at outpatient clinics typically runs $1,800-$3,000. Coverage varies significantly by protocol type and setting.
The real member experience: what TMS sessions feel like week by week
TMS sessions involve a rhythmic tapping sensation that members typically adjust to over a multi-week course, progressing from initial scalp sensitivity to noticeable mood improvements by week four. Walking into a Manhattan TMS clinic, you transition from the noise and rush of the city streets to a quiet environment designed to put you at ease.
Before your first session, a clinician will measure your head and use gentle magnetic pulses to locate your motor threshold—the minimum intensity needed to make your thumb twitch involuntarily. This calibration ensures your treatment is precisely dosed for your individual neurobiology. Once the optimal position and intensity are established, you’ll settle into a comfortable reclining chair while the magnetic coil is positioned against your scalp.
Each pulse creates a rhythmic clicking sound and a gentle knock against your head, like someone tapping their fingernail on your skull in rapid succession. Some members describe it as oddly meditative once they adjust to the rhythm. You remain fully awake and aware throughout—you might read, listen to music, or simply rest with your eyes closed. There’s no altered state of consciousness, no drowsiness, and no need for supervision afterward.
Common side effects and timeline:
- Week 1: Mild headache or scalp discomfort, typically manageable with over-the-counter pain relief
- Week 2: Side effects diminish as your nervous system adjusts
- Weeks 1–2: Minimal noticeable changes as neural circuits begin responding
- Weeks 3–4: Early improvements emerge—members report feeling more engaged, fewer intrusive negative thoughts, or lighter mood
- After treatment: Can resume daily activities immediately—driving, working, or socializing without impairment
TMS vs. ketamine and Spravato: a decision framework
TMS requires 4–6 weeks for effect while intravenous (IV) ketamine can show relief within days and Spravato (esketamine nasal spray) offers an insurance-covered middle ground—critical differences for members in acute distress or weighing coverage options. A 2025 network meta-analysis comparing multiple randomized trials of rapid-acting depression treatments found no significant difference in remission rates between IV ketamine and rTMS, though ketamine showed better acceptability—meaning participants were more likely to complete treatment and report satisfaction.
TMS is non-sedating and mechanical, working through repeated brain stimulation during brief outpatient sessions. Ketamine, by contrast, allows for dissociation (a feeling of detachment from one’s thoughts or body) and deeper experiential processing during the infusion itself. Many members describe ketamine sessions as profoundly introspective, creating space to observe difficult emotions from a safe distance.
For acute distress or comorbid post-traumatic stress disorder (PTSD), IV ketamine’s rapid onset may be preferred—supported by the 2025 study “Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm” by Henry A MacConnel, Mitch Earleywine, Steven Radowitz. When depression is accompanied by trauma, suicidal ideation, or severe anxiety requiring immediate intervention, waiting several weeks for TMS may not be realistic or safe.
Nushama’s decision framework helps members evaluate insurance-covered esketamine versus the deeper experiential processing of IV infusions. Spravato offers a more accessible entry point if you require an FDA-approved, insurance-reimbursable medication. However, many clinicians find that IV ketamine allows for more precise dosing control and a more immersive therapeutic experience.
Integration (the process of reflecting on and making meaning from the treatment experience) is essential to durable change with ketamine therapy. Unlike TMS, which works primarily through repeated neural stimulation, ketamine creates windows of heightened neuroplasticity that must be actively leveraged through intentional reflection, therapy, and behavior change.
When choosing between approaches, consider your timeline for relief, your comfort with experiential versus mechanical treatments, your insurance coverage and budget, and whether you have access to strong preparation and integration support.
Frequently asked questions about TMS therapy
Does TMS therapy hurt?
Most members report a tapping sensation or mild scalp discomfort, not pain. The feeling is mechanical rather than sharp. Side effects typically fade after the first few sessions as your nervous system adjusts to the stimulation pattern.
Is TMS covered by insurance?
Most major insurers cover standard rTMS for treatment-resistant depression after you’ve tried and not responded to multiple antidepressants. Accelerated protocols like SAINT are less commonly covered, though some insurers are beginning to include them. Prior authorization usually requires documentation of your treatment history and a formal diagnosis.
Can I drive after a TMS session?
Yes—TMS does not cause sedation, so you can resume daily activities immediately. Unlike some psychiatric medications or ketamine therapy, there’s no period of impairment following treatment. Most members schedule sessions during lunch breaks or on their way to other appointments without disruption to their day.
How long does it take to see results?
Standard TMS shows noticeable improvements around week 3 or 4 as cumulative neural changes take hold. SAINT protocol members may experience remission within days , though this accelerated timeline isn’t appropriate for everyone. If you’re considering ketamine instead, our guide on what to expect walks through the session-by-session timeline for that modality, including how preparation and integration support the healing process.
If you’re ready to explore how TMS or other advanced treatments might support your journey, speak with our care team .
